|
Home
CME Live Seminars
About the Program
Quick Order
Hotel Registration
Auto Rental
Accreditation
Cancellation Policy
Testimonials
CME Video DVD
CME Audio CD/MP3
Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us
|
|
|
|
Live CME Seminars
Internal Medicine CME |
|
|
by Michael P. Goldfinger, M.D., F.A.C.P. - Jefferson Medical College, Thomas Jefferson University; Assistant Professor of Medicine; Director, Continuous Quality Improvement and Director, Peer/Mortality Review, Department of Medicine, Division of General Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA; Merri L. Pendergrass, M.D., Ph.D. - Harvard Medical School; Associate Professor of Medicine; Vice President, National Practice Leader in Diabetes, Medco Health Solutions, Inc., Fort Worth, TX; Gerald W. Smetana, M.D. - Harvard Medical School; Associate Professor of Medicine; Director of CME, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA and C. Christopher Smith, M.D. - Harvard Medical School; Associate Professor of Medicine; Associate Director, Internal Medicine Residency Training Program, Associate Firm Chief, Blumgart Medical Firm, and Co-Director, Rabkin Fellowship
in Medical Education, Beth Israel Deaconess Medical Center of Harvard Medical School, Boston, MA.
Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website
|
|
Internal Medicine: A Clinical Update
March 15-19, 2010
Location: Hyatt Regency Sarasota, Florida
| SPECIFIC OBJECTIVES
| | Day 1 | Thyroid Nodules - Upon completion of this session, the participant should be able to:
| 1. | Describe the incidence of thyroid nodules in the primary care setting.
| | 2. | Discuss features from history and physical examination that increase the likelihood of malignancy.
| | 3. | Outline the best diagnostic approach to a thyroid nodule.
| | 4. | Review common cytologic findings from fine needle aspirate and their clinical significance.
| | Dizziness in the Primary Care Setting - Upon completion of this session, the participant should be able to:
| | 1. | Differentiate between the most common causes of dizziness.
| | 2. | Distinguish between central and peripheral causes of vertigo.
| | 3. | Describe physical examination maneuvers used to diagnose and treat vertigo.
| | Important Drug Interactions and Side Effects - Upon completion of this session, the participant should be able to:
| | 1. | Discuss the most common mechanisms for drug interactions.
| | 2. | Identify some of the most frequent culprit drugs.
| | 3. | Counsel patients regarding some of the most frequent side-effects seen with commonly used medications.
| | Approach to the Patient with Syncope - Upon completion of this session, the participant should be able to:
| | 1. | Discuss the various etiologies of syncope.
| | 2. | Use clues in the history and physical as well as simple office testing to risk-stratify patients.
| | 3. | Develop a plan for appropriate use of additional testing in patients with syncope.
| | 4. | Gain an appreciation of the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.
|
| | Day 2 | Peripheral Arterial Disease (PAD) – A Primary Care Perspective - Upon completion of this session, the participant should be able to:
| 1. | Describe the pathophysiology of arteriosclerosis, the most common cause of PAD.
| | 2. | Identify patients at increased risk for PAD.
| | 3. | Perform a focused history and physical examination to assess for PAD.
| | 4. | Have an appreciation of the role of ancillary testing.
| | 5. | Develop a plan for management of patients with PAD utilizing evidence-based guidelines for exercise, medications and revascularization.
| | Outpatient Anticoagulation Issues – What’s Important in Primary Care? - Upon completion of this session, the participant should be able to:
| | 1. | Manage outpatient warfarin using current guidelines.
| | 2. | Describe when and how to reverse the effects of warfarin.
| | 3. | Evaluate patients for hypercoagulable states and appreciate the implications.
| | 4. | Advise patients on the appropriate duration and intensity of anticoagulation in a variety of clinical scenarios.
| | Abnormal Liver Tests: Case Studies for the Primary Care Provider - Upon completion of this session, the participant should be able to:
| | 1. | Describe a diagnostic approach to assess patients with asymptomatic elevations in liver studies.
| | 2. | Describe the common causes of asymptomatic elevations in transaminase levels.
| | 3. | Review the natural history of hepatitis B infection, including serologic markers and indications for treatment.
| | 4. | Review the epidemiology, evaluation and potential treatment options for nonalcoholic steatohepatitis.
| | Dyslipidemia - Upon completion of this session, the participant should be able to:
| | 1. | Apply recent changes to ATP III lipid management guidelines to their clinical practice.
| | 2. | Recognize secondary causes of dyslipidemia.
| | 3. | Describe treatment strategies for various dyslipidemic states.
|
| | Day 3 | Assessment of the Painful Knee in a Primary Care Setting - Upon completion of this session, the participant should be able to:
| 1. | Recognize key historical features to help distinguish between common causes of knee pain in the primary care setting.
| | 2. | Demonstrate physical examination skills utilized in the diagnosis of common causes of knee pain.
| | 3. | Describe the treatment of common knee injuries in the primary care setting and determine which injuries require orthopedic consultation.
| | Assessment of the Painful Shoulder in the Primary Care Setting - Upon completion of this session, the participant should be able to:
| | 1. | Review the anatomy of the shoulder in relation to common mechanisms of injury.
| | 2. | Describe and utilize key historical and physical examination skills needed to accurately diagnose common causes of shoulder pain in the primary care setting.
| | 3. | Describe the initial management of common shoulder injuries.
| | Diagnosis of Primary Headache Syndromes - Upon completion of this session, the participant should be able to:
| | 1. | Discuss the historical features of migraine, tension-type, and cluster headache.
| | 2. | Recognize which historical features best discriminate between migraine and tension-type headache.
| | 3. | List the triggers for migraine.
| | Treatment of Primary Headache Syndromes - Upon completion of this session, the participant should be able to:
| | 1. | Appreciate the role of abortive therapy for migraine, tension-type, and cluster headache.
| | 2. | Recognize the range of options for pharmacologic preventive therapy for migraine, tension-type, and cluster headache.
| | 3. | Develop non-pharmacologic treatment strategies for migraine.
|
| | Day 4 | Prevention of Type 2 Diabetes - Upon completion of this session, the participant should be able to:
| 1. | Identify patients with pre-diabetes.
| | 2. | Describe recommendations of professional organizations regarding diabetes prevention.
| | 3. | Treat CVD risk factors in patients with pre-diabetes.
| | Treatment of Hyperglycemia in Type 2 Diabetes - Upon completion of this session, the participant should be able to:
| | 1. | Understand the glucose targets in T2DM.
| | 2. | Describe current pharmacological treatment options.
| | 3. | Develop individualized regimens to optimize glycemic control.
| | Preoperative Cardiac Evaluation - Upon completion of this session, the participant should be able to:
| | 1. | Develop risk stratification for perioperative cardiac risk.
| | 2. | Demonstrate knowledge of preoperative cardiac risk guidelines and the revised cardiac risk index.
| | 3. | Properly use beta-blockers and statins for patients at risk for perioperative cardiac complications.
| | Preoperative Pulmonary Evaluation - Upon completion of this session, the participant should be able to:
| | 1. | Identify patient and procedure-related risk factors for postoperative pulmonary complications.
| | 2. | Appreciate the limited role of preoperative spirometry.
| | 3. | Apply strategies to reduce the risk of postoperative pulmonary complications.
|
| | Day 5 | Approach to the Patient with Hypertension - Upon completion of this session, the participant should be able to:
| 1. | Appreciate that all antihypertensive medications do not equally reduce cardiovascular risk.
| | 2. | Apply the JNC-7 guidelines to clinical care of hypertensive patients.
| | 3. | Recognize compelling indications for selection of initial antihypertensive therapy.
| | 4. | Identify which drugs most effectively reduce the risk of cardiovascular disease.
| | New Drugs for the Primary Care Physician: What You Need to Know - Upon completion of this session, the participant should be able to:
| | 1. | Survey important advances in pharmacotherapy that pertain to primary care practice.
| | 2. | Discuss the efficacy and list the side effects for each drug.
| | 3. | Compare key new drugs with previously available medications for similar indications.
| | Common Thyroid Disorders - Upon completion of this session, the participant should be able to:
| | 1. | Diagnose common causes of thyroid hyper-function and hypo-function.
| | 2. | Treat common thyroid function abnormalities.
| | 3. | Perform an appropriate evaluation of thyroid nodules.
| | Common Endocrine Disorders - Upon completion of this session, the participant should be able to:
| | 1. | Recognize, evaluate and treat common endocrine abnormalities including:
| a. | Hypoglycemia,
| | b. | Hypercalcemia,
| | c. | Low testosterone,
| | d. | Adrenal masses.
|
|
|
|